Ontology highlight
ABSTRACT:
SUBMITTER: D'Agostino M
PROVIDER: S-EPMC7662679 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
D'Agostino Mattia M Innorcia Salvatore S Boccadoro Mario M Bringhen Sara S
International journal of molecular sciences 20201101 21
Immunotherapy is increasingly used in the treatment of multiple myeloma (MM). Monoclonal antibodies (mAbs) are safe and effective ways to elicit immunotherapeutic responses. In 2015, daratumumab has become the first mAb approved by the Food and Drug Administration for clinical use in MM and, in the last 5 years, a lot of clinical and preclinical research has been done to optimize the use of this drug class. Currently, mAbs have already become part of standard-of-care combinations for the treatme ...[more]